Best Cathy Hannes Podcasts (2025)

1
Life In Remission 21:37

10d ago21:37

21:37

Hello Cancer Friends! After nearly a year, Hello Cancer Friends is back. Today I will discuss my life in remission. Cancer is a game changer and life hasn't been the same since my diagnosis of pancreatic cancer in 2019. While the appreciation of survival is beyond words, it isn't always easy to just pick up where you leave off. I think I've figured…

1
In conversation with... Salvatore Piano 19:05

28d ago19:05

19:05

How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis? We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents.…

1
Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis 19:05

29d ago19:05

19:05

How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis? We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents. Read the full …

1
John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer 13:29

2M ago13:29

13:29

John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00387-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation…

1
In conversation with... John Chia 13:29

2M ago13:29

13:29

John Chia discusses the results of the ASCOLT trial, which explored the effect of aspirin after completion of standard adjuvant therapy for patients with colorectal cancer.By The Lancet

1
In conversation with... Hannes Hagström 21:23

4M ago21:23

21:23

Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes.By The Lancet

1
Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes 21:23

4M ago21:23

21:23

Hannes Hagström discusses a study investigating the feasibility of screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00313-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social…

1
In conversation with... Cathy Lu 11:15

5M ago11:15

11:15

Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease.By The Lancet

1
Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures 11:15

5M ago11:15

11:15

Cathy Lu (University of Calgary) discusses a consensus statement on the use of intestinal ultrasound for assessing and monitoring small bowel strictures in Crohn's disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00265-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation…

1
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis 14:42

6M ago14:42

14:42

Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00200-0?dgcid=buzzsprout_icw_podcast_generic_langas Continue this co…

1
In conversation with... Peter De Cruz 14:42

6M ago14:42

14:42

Peter De Cruz (University of Melbourne) discusses the PREDICT-UC trial of intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.By The Lancet

1
Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease 34:15

6M ago34:15

34:15

Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small molecules in inflammatory bowel disease. Read the full articles: https://www.thelancet.com/journals/…

1
In conversation with... Shahida Din and Beatriz Gros 34:15

6M ago34:15

34:15

Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small molecules in inflammatory bowel disease.By The Lancet

1
In conversation with... Arndt Vogel 18:31

9M ago18:31

18:31

Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.By The Lancet

1
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer 18:23

9M ago18:23

18:23

Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5?dgc…

1
In conversation with... Nancy Baxter 25:05

10M ago25:05

25:05

Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.By The Lancet

1
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy 25:05

10M ago25:05

25:05

Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversatio…

1
In conversation with... Sanna Nybacka and Magnus Simrén 23:16

12M ago23:16

23:16

Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.By The Lancet

1
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS 23:16

12M ago23:16

23:16

Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas …

1
In conversation with... Nuru Noor 19:55

1y ago19:55

19:55

Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease.By The Lancet

1
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease 19:55

1y ago19:55

19:55

Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00034-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Foll…

1
#86 When Hope Is Not Enough 11:24

1y ago11:24

11:24

The unfortunate reality of cancer is that you can hope all you want and sometimes it will not change the outcome. My mind was in that place prior to my genetic breakthrough. Not everyone is as lucky. In this episode, I share what helped me to get through a time when my demise was the only logical future I had.…

1
In conversation with... Yusuke Shimakawa 20:54

1y ago20:54

20:54

Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.By The Lancet

1
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa 20:54

1y ago20:54

20:54

Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... http…

1
#85 Mary 56:23

1y ago56:23

56:23

Meet Mary! Having cancer is scary. Having a rare cancer adds other challenges when there is a lack of information. Mary explains how she has learned to navigate her situation as well as how she's met some great professionals to help her through! Thank you so much for sharing your story, Mary!By Cathy Hannes

1
#84 Jennifer 58:18

1y ago58:18

58:18

Meet Jennifer! She has gone through so much, yet has taken the time to join us today to share her amazing story. There is so much to learn while living this experience. Jennifer has taken good notes and is sharing so many helpful lessons. Hello Cancer Friends is so lucky to know you! Thank you!By Cathy Hannes

1
#83 Hello Cancer Friends Is Back! Again! 14:23

1y ago14:23

14:23

Hi Friends! Quick update on my surgery adventure and Happy 3rd Year Anniversary to Hello Cancer Friends! I could not do this without my friends. XOXO!By Cathy Hannes

1
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake 16:39

1y ago16:39

16:39

Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this convers…

1
In conversation with... Mads Israelsen 16:39

1y ago16:39

16:39

Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.By The Lancet

1
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity 23:19

1y ago23:19

23:19

Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on socia…

1
In conversation with... Louise Dye 23:19

1y ago23:19

23:19

Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity.By The Lancet

1
#82 Tommy 1:04:37

1+ y ago1:04:37

1:04:37

Acinar Cell Carcinoma twinsie, Tommy, shares his story. You'll laugh, you'll cry. All the feels in this one! Thank you Tommy! You are the best!By Cathy Hannes

1
#81 Ann 1:16:59

1+ y ago1:16:59

1:16:59

2024 is starting out strong with a wonderful visit from my new friend Ann! Her story will captivate you. She's been through a lot and still keeps going with faith in her heart and a smile on her face. Thank you Ann, you are amazing.By Cathy Hannes

1
#80 2024! 8:40

1+ y ago8:40

8:40

Resolutions, no. Thankful, yes. Happy New Year!By Cathy Hannes

1
In conversation with... Tzu-Chan Hong 14:40

1+ y ago14:40

14:40

Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region.By The Lancet

1
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region 14:40

1+ y ago14:40

14:40

Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_gen…

1
#79 Tis the Season! 10:49

1+ y ago10:49

10:49

Leave your stress behind! Top 10 stress reducers for the holiday season on this episode of HELLO CANCER FRIENDS!By Cathy Hannes

1
#78 Gracie 58:12

1+ y ago58:12

58:12

Every so often I remember the silver linings of having cancer. This would be one of those moments. Meet Gracie. She's not afraid to share her story and she's spreading awareness far and wide about young patients needing to advocate for themselves. There is so much more to Gracie including raw and real poetry. Experience the emotions and for some, v…

1
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy 14:45

1+ y ago14:45

14:45

Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=…

1
In conversation with... Sarah Moen 14:45

1+ y ago14:45

14:45

Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants.By The Lancet

1
#77 Thanks, No Thanks 12:10

1+ y ago12:10

12:10

For this special Thanksgiving episode, I'll be serving up another word salad about my own personal story and how sometimes, I am not thankful. I'm going to say it out loud as I continue to keep it real here on Hello Cancer Friends! Thanks for listening!By Cathy Hannes

1
#76 SMILE! 33:28

1+ y ago33:28

33:28

Hello Cancer Friends is BACK and we are so excited to bring to you Dr. Jessica Pharar, as she shares her heartwarming story. Cancer is cruel and can break your heart. Sometimes it also helps to turn the most difficult situation into one that can help others. Carrying on the tradition of giving and generosity of her Dad, Jessica shares her drive to …

1
In conversation with... Anna Emilie Kann 16:19

1+ y ago16:19

16:19

Anna Emilie Kann (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease.By The Lancet

1
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease 16:19

1+ y ago16:19

16:19

Anna Emilie Kann (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue t…

1
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction 16:31

1+ y ago16:31

16:31

Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversati…

1
In conversation with... Robert Krouse 16:31

1+ y ago16:31

16:31

Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction.By The Lancet

1
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis 14:29

2y ago14:29

14:29

Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases. Read the full article: https://www.thelancet.com/journals/langas/art…

1
In conversation with... Marc Rothenberg 14:29

2y ago14:29

14:29

Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.By The Lancet

1
In conversation with... Michael Pavlides 17:41

2y ago17:41

17:41

Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.By The Lancet

1
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease 17:41

2y ago17:41

17:41

Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this c…

Podcasts Worth a Listen

Cathy Hannes Podcasts

Podcasts Worth a Listen

Quick Reference Guide